Clinical Trials Directory

Trials / Unknown

UnknownNCT05132621

The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.

The Genital Tract Microflora in Women With Systemic Lupus Erythematosus and IgA Nephropathy.

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

The study hypothesis: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a broad spectrum of clinical manifestations. Its mechanisms are not well understood. It is known that its development is influenced by genetic factors and gender. However, it is believed that in some patients with a specific genetic predisposition, certain environmental factors such as chemicals, including drugs and toxins, smoking, or infections may initiate the development of the disease. Of particular importance seem to be infections, which by stimulating the immune system can induce new symptoms or exacerbate existing ones. For this reason, links between the microbiome and the clinical course of SLE are being sought. Most available studies concern the intestinal microbiome. So far, the relationship between the genital tract microbiota and the clinical picture of SLE has not been documented. Aim of the study: This study aims to identify and differentiate the genital tract microbiota of women with a diagnosis of systemic lupus, IgA nephropathy and a control group of healthy women. The results will be correlated with the clinical presentation of these diseases. In addition, the isolated bacterial strains will be secured for further study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSmearA smear of the posterior vaginal fornix collected with a gynecological speculum.

Timeline

Start date
2021-11-01
Primary completion
2022-12-01
Completion
2023-12-01
First posted
2021-11-24
Last updated
2021-11-24

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT05132621. Inclusion in this directory is not an endorsement.